Saga plc (GB:SAGA)
LSE:SAGA
Holding GB:SAGA?
Track your performance easily

Saga plc (SAGA) Income Statement

44 Followers

Saga plc Income Statement

Last quarter (Q4 2023), Saga plc's total revenue was £―, a decrease of ― from the same quarter last year. In Q4, Saga plc's net income was £―. See Saga plc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jan 23Jan 22Jan 21Jan 20Jan 19
Total Revenue
-£ 792.80M£ 565.91M£ 337.60M£ 797.30M£ 841.50M
Cost of Revenue
-£ 407.60M£ 208.20M£ 100.20M£ 425.90M£ 405.00M
Gross Profit
-£ 385.20M£ 357.71M£ 237.40M£ 371.40M£ 436.50M
Operating Expense
-£ 325.40M£ 345.30M£ 202.90M£ 247.10M£ 246.10M
Operating Income
-£ 59.80M£ 12.41M£ 34.50M£ 124.30M£ 190.40M
Net Non Operating Interest Income Expense
-£ -37.40M£ -33.70M£ -25.20M£ -14.90M£ -7.80M
Other Income Expense
-£ 272.90M£ 1.80M---
Pretax Income
-£ -254.20M£ -27.89M£ -61.20M£ -300.90M£ -134.80M
Tax Provision
-£ 5.00M£ 4.50M£ 6.60M£ 11.90M£ 27.40M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-£ -259.20M£ -32.39M£ -67.80M£ -312.80M£ -162.20M
Basic EPS
-£ -1.86£ -0.20£ -0.67£ -3.82£ -1.98
Diluted EPS
-£ -1.86£ -0.20£ -0.67£ -3.82£ -1.98
Basic Average Shares
-£ 139.50M£ 139.50M£ 101.20M£ 81.90M£ 81.92M
Diluted Average Shares
-£ 139.50M£ 139.50M£ 101.20M£ 81.90M£ 81.92M
Dividend Per Share
---£ 0.00£ 0.31£ 1.23
Total Operating Income As Reported
------
Reported Normalized Basic E P S
---£ 0.13£ 1.21£ 1.79
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
---£ 200.00K£ 300.00K£ 200.00K
Total Expenses
-£ 733.00M£ 553.50M£ 303.10M£ 673.00M£ 651.10M
Net Income From Continuing And Discontinued Operation
-£ -259.20M£ -32.39M£ -67.80M£ -312.80M£ -162.20M
Normalized Income
-£ 68.90M£ -14.19M£ 45.38M£ 398.17M£ 400.28M
Interest Expense
---£ 30.20M£ 20.70M£ 12.60M
EBIT
-£ -212.00M£ 10.21M£ -31.00M£ -280.20M£ -122.20M
EBITDA
-£ 99.50M£ 53.01M£ 56.40M£ 171.60M£ 243.10M
Currency in GBP

Saga plc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis